8-K: XWELL Secures $4 Million in Private Placement to Fuel Expansion and Innovation

XWELL, Inc. has successfully closed a $4 million private placement, issuing convertible preferred stock and warrants to support its growth strategy.

Summary

• XWELL, Inc. closed a private placement, raising $4 million through the sale of Series G Convertible Preferred Stock and warrants.
• The offering included Series A and Series B warrants, exercisable for common stock at $1.496 and $1.7952 per share, respectively.
• The company intends to use the net proceeds for working capital and general corporate purposes, including the development of AI-driven products and expansion of XWELL locations.
• The full conversion of the preferred stock and exercise of the warrants are subject to stockholder approval.
• The securities were offered and sold in transactions exempt from registration under the Securities Act of 1933.

Sentiment

Score: 7

Explanation: The document is generally positive, highlighting the successful capital raise and future growth plans. However, the need for stockholder approval and potential dilution are factors that temper the overall sentiment.

Positives

• The private placement provides XWELL with $4 million in gross proceeds to support its strategic initiatives.
• The funding will enable the company to develop and deploy innovative AI-driven health, wellness, and beauty products.
• The capital will support the expansion of XWELL locations beyond airports.
• The company is already activating against the strategy set forth in late 2024.

Negatives

• The full conversion of the preferred stock and exercise of the warrants are subject to stockholder approval, which could introduce uncertainty.
• The company is obligated to pay certain liquidated damages to the investors if the company fails to file the registration statement when required, fails to cause the registration statement to be declared effective by the SEC when required, or fails to maintain the effectiveness of the registration statement pursuant to the terms of the Registration Rights Agreement.

Risks

• The company's ability to settle conversions and make amortization and dividend make-whole payments using shares of Common Stock is subject to certain limitations set forth in the Certificate of Designations, including a limit on the number of shares that may be issued until the time, if any, that the Company has obtained the Stockholder Approval.
• The Certificate of Designations includes certain Triggering Events, including, among other things, the Companys failure to pay any amounts due to the holders of the Preferred Stock when due. In connection with a Triggering Event, each holder of Preferred Stock will be able to require the Company to redeem in cash any or all of the holders Preferred Stock at a premium set forth in the Certificate of Designations.
• The Company is subject to certain affirmative and negative covenants regarding the incurrence of indebtedness, the existence of liens, the repayment of indebtedness, the payment of cash in respect of dividends (other than dividends pursuant to the Certificate of Designations), distributions or redemptions, and the transfer of assets, among other matters.
• The Company is required to maintain at all times unencumbered, unrestricted cash and cash equivalents on hand in amount equal to at least 200% of the Conversion Amount (as defined in the Certificate of Designations) of the outstanding shares of Preferred Stock.

Future Outlook

XWELL intends to use the net proceeds of this private placement for working capital and general corporate purposes as part of the strategy outlined in the shareholder letter dated December 5, 2024. This funding will empower us to advance the development and deployment of innovative AI-driven health, wellness, and beauty products, said CEO Ezra Ernst. It will also support the continued expansion of our XWELL locations beyond airports and enable us to further enhance our integrated branding efforts.

Management Comments

• This funding will empower us to advance the development and deployment of innovative AI-driven health, wellness, and beauty products, said CEO Ezra Ernst.
• It will also support the continued expansion of our XWELL locations beyond airports and enable us to further enhance our integrated branding efforts.
• This move proves that we are already activating against the strategy set forth in late 2024.

Industry Context

The private placement reflects a trend of companies seeking capital to fund growth and innovation in the health and wellness sector, particularly those leveraging AI and digital technologies. This move positions XWELL to compete more effectively in the market.

Comparison to Industry Standards

• The use of convertible preferred stock and warrants is a common financing method for growth-stage companies in the health and wellness industry.
• The specific terms of the warrants, such as the exercise prices and expiration dates, are within the typical range for such instruments.
• The company's plan to use the proceeds for AI-driven product development and expansion aligns with industry trends towards technology-enabled wellness solutions.
• The requirement for stockholder approval for full conversion and exercise is a standard practice to ensure compliance with listing rules.

Stakeholder Impact

• Shareholders may experience dilution upon conversion of the preferred stock and exercise of the warrants.
• Employees may benefit from the company's growth and expansion plans.
• Customers may benefit from the development of new AI-driven health and wellness products.
• Creditors may be impacted by the company's use of proceeds and financial performance.

Next Steps

• The company will file a registration statement with the SEC for the resale of common stock issuable upon conversion of the preferred stock and exercise of the warrants.
• The company will seek stockholder approval for the full conversion of the preferred stock and exercise of the warrants.
• The company will use the net proceeds for working capital, general corporate purposes, and to advance AI-driven health and wellness products.

Key Dates

Keywords

private placement, convertible preferred stock, warrants, common stock, capital raise, AI, wellness, XWELL, Series G Preferred Stock, Series A warrants, Series B warrants